Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Cutaneous Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04079166
What this trial is testing

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

Who this might be right for
Malignant MelanomaMelanoma (Skin)Melanoma Stage III+1 more
Scancell Ltd 173
Testing effectiveness (Phase 2)UnknownNCT05429866
What this trial is testing

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Who this might be right for
Breast CancerMelanomaNon Small Cell Lung Cancer+10 more
Jules Bordet Institute 441
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Early research (Phase 1)Active Not RecruitingNCT01480154
What this trial is testing

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmStage III Cutaneous Melanoma AJCC v7Stage III Prostate Cancer AJCC v7+7 more
National Cancer Institute (NCI) 62
Early research (Phase 1)Study completedNCT06014086
What this trial is testing

Intratumoral PH-762 for Cutaneous Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the SkinMalignant Melanoma of SkinMerkel Cell Carcinoma of Skin
Phio Pharmaceuticals Inc. 22
Early research (Phase 1)Study completedNCT00003897
What this trial is testing

Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 18
Testing effectiveness (Phase 2)Study completedNCT00005968
What this trial is testing

Irofulven in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT01902173
What this trial is testing

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid NeoplasmLocally Advanced Melanoma+6 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00014092
What this trial is testing

Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery

Who this might be right for
Melanoma (Skin)
Saint Francis Hospital
Early research (Phase 1)Study completedNCT00705640
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)
Craig L Slingluff, Jr 45
Not applicableUnknownNCT00070343
What this trial is testing

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Large-scale testing (Phase 3)UnknownNCT02962947
What this trial is testing

MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients

Who this might be right for
Melanoma
Azienda Sanitaria di Firenze 546
Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT01320085
What this trial is testing

A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma

Who this might be right for
BRAF or NRAS Mutant Metastatic Melanoma
Pfizer 183
Testing effectiveness (Phase 2)Study completedNCT01972347
What this trial is testing

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 35
Not applicableEnded earlyNCT04941430
What this trial is testing

7T MRI Scan for the Early Detection of Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
University of Southern California 2
Testing effectiveness (Phase 2)Study completedNCT01502293
What this trial is testing

Trial of pIL-12 Electroporation Malignant Melanoma

Who this might be right for
Melanoma
OncoSec Medical Incorporated 51
Next Page